Acceder

Publicaciones - Biomembranas y Señalización Celular

Cargando...
Serrano-Lopez EM, Lopez-Martinez D, Gomez-Fernandez JC, Egea-Jimenez AL, Corbalan-Garcia S. PKCepsilon controls the fusion of secretory vesicles in mast cells in a phosphatidic acid-dependent mode. Int J Biol Macromol. 2021 Aug 31;185:377-389. doi: 10.1016/j.ijbiomac.2021.06.019. Epub 2021 Jun 18. PubMed PMID: 34147527.
AÑO: 2021; IF: 8.025
Haugaard-Kedström LM, Clemmensen LS, Sereikaite V, Jin Z, Fernandes EFA, Wind B, Abalde-Gil F, Daberger J, Vistrup-Parry M, Aguilar-Morante D, Leblanc R, Egea-Jimenez AL, Albrigtsen M, Jensen KE, Jensen TMT, Ivarsson Y, Vincentelli R, Hamerlik P, Andersen JH, Zimmermann P, Lee W, Strømgaard K. A High-Affinity Peptide Ligand Targeting Syntenin Inhibits Glioblastoma. J Med Chem. 2021 Feb 11;64(3):1423-1434. doi: 10.1021/acs.jmedchem.0c00382. Epub 2021 Jan 27. PubMed PMID: 33502198.
AÑO: 2021; IF: 8.039
Kashyap R, Balzano M, Lechat B, Lambaerts K, Egea-Jimenez AL, Lembo F, Fares J, Meeussen S, Kügler S, Roebroek A, David G, Zimmermann P. Syntenin-knock out reduces exosome turnover and viral transduction. Sci Rep. 2021 Feb 18;11(1):4083. doi: 10.1038/s41598-021-81697-4. PubMed PMID: 33602969; PubMed Central PMCID: PMC7892569.
AÑO: 2021; IF: 4.996
Zimmermann P, Egea-Jimenez AL. Study of PDZ-Peptide and PDZ-Lipid Interactions by Surface Plasmon Resonance/BIAcore. Methods Mol Biol. 2021;2256:75-87. doi: 10.1007/978-1-0716-1166-1_5. PubMed PMID: 34014517.
AÑO: 2021
Garcia M, Hoffer L, Leblanc R, Benmansour F, Feracci M, Derviaux C, Egea-Jimenez AL, Roche P, Zimmermann P, Morelli X, Barral K. Fragment-based drug design targeting syntenin PDZ2 domain involved in exosomal release and tumour spread. Eur J Med Chem. 2021 Nov 5;223:113601. doi: 10.1016/j.ejmech.2021.113601. Epub 2021 Jun 5. PubMed PMID: 34153575.
AÑO: 2021; IF: 7.088
Siguiente >

Instituto de Investigación Sanitaria Acreditado

ISCII